期刊文献+

原发性高血压患者血浆第Ⅷ因子相关抗原和脂质过氧化物浓度的变化 被引量:2

下载PDF
导出
摘要 目的 :研究氧自由基与内皮细胞损伤的关系。方法 :对 2 5例原发性高血压 (EH)患者和 2 0例正常人 ,采用酶联免疫吸附法测定血浆中反映血管内皮细胞 (VEC)损伤的指标———第Ⅷ因子相关抗原 (vWF) ,硫代巴比妥酸法测定血浆中反映氧自由基损伤水平的脂质过氧化物 (LPO)。结果 :EH患者血浆vWF和LPO浓度均显著高于正常对照组 (P <0 0 1) ,且LPO与vWF浓度呈显著的正相关 (r =0 5 61,0 0 0 2 5 >P >0 0 0 1)。结论 :EH患者存在有VEC损伤 ,氧自由基是导致VEC损伤的重要因素之一。
出处 《河南诊断与治疗杂志》 2000年第2期73-73,76,共2页 Henan Journal of Diagnosis and Therapy
  • 相关文献

参考文献9

  • 1Meredith IT,Andersom TJ,Uehata A,et al.Role of endothelium in ischemic coronary ayndromes.AM J Cardiol,1993,172(1):27.
  • 2Blann AD,Mocollum CN.von Willebrand factor,endothelial cell darnage and atherosclerosis.Eur J Vase Sury,1994,8(1):10.
  • 3Hammond B,Hess ML.The oxygen free radical system:potential mediator of myocardial injury.J AM Coll Cardiac,1986,6(2):215.
  • 4WHO Expert Committee.Arterial hypertension(WHO technical report series 628),1978:9.
  • 5Short PE,Williams CE,Picken AM,et al.Factor Ⅷ related antigen:an improved enzyme immunoassay.Med Lab Sci,1982,39(4):351.
  • 6内藤周幸.过酸化脂质[J].日本临床,1982,40:288-288.
  • 7Dohi Y,Thlel MA,Buhler FR,et al.Activation of endothelial L-arginine pathway in pressurized mesenteric resistance arteries.Effect of age on hypertension.Hypertension,1990,15(2):170.
  • 8Lusher TF,Seo BG,Buhler FR.Potential role of endothelin in hypertension.Controversy on endothelin in hypertension.Hypertension,1993,21(5):752.
  • 9杨向红,陈铁镇.维生素E对培养人内皮细胞脂质过氧化损伤的保护作用[J].中国医科大学学报,1992,21(6):405-408. 被引量:4

二级参考文献3

共引文献4

同被引文献13

  • 1尚晓滨,吴咸中,李东华,郭世铎.活血化瘀中药对清解通下中药增效作用的实验研究I——治疗急性细菌性腹膜炎的实验观察[J].中国中西医结合外科杂志,2006,12(2):91-94. 被引量:13
  • 2冷兴文,刘志华,罗书练.血清丙二醛和超氧化物歧化酶水平与病情转归的关系[J].中国危重病急救医学,1996,8(10):598-600. 被引量:22
  • 3Kugiyama K, Kerns S, Morrisett J, et al. Impairment of endothelium dependent arterial relaxation by lysolecithin in modified low-density lipoproteins [J]. Nature, 1990, 344 (6262): 160-162.
  • 4Yamaoto N, Ostuka Y, Kushiro J. Role of superoxide anion on onset and maintenance of hypertension in spontaneously hypertensive rat [J].Nippon Jinzo Gakki Shi, 1992, 34 (6): 717-732.
  • 5[2]Whawell SA,Scott-Coombes DM,Vipond MN,et al.Tumor necrosis factor-mediated release of plasminogen activator inhibitor by human peritoneal mesothelial cells[J].BrJ Surg,1994,81(6):214
  • 6[3]Van Hinsbergh VW,Van den Berg EA,Fiers W,et al.Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells[J].Blood,1990,75(3):1 991
  • 7[5]Herndon DN,Nguyen TT,Gilpin DA.Growth factors,Local and systemic[J].Arch Surg,1993,128(5):1 227
  • 8[6]Falk P,Ma C,Chegini N,et al.Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1[J].Scand J Clin Lab Invest,2000,60(3):439
  • 9[7]Senger DR.Vascular permeability factor (VPF,VEGF) in tumor biology[J].Cancer Metastasis Rev,1993,12(2):303
  • 10[9]Weidner N,Carroll PR,Flax J,et al.Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma[J].Am J Pathol,1993,143(4):401

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部